Marshall Wace North America’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-39,918
Closed -$2.27M 1701
2017
Q3
$2.27M Buy
39,918
+28,463
+248% +$1.42M 0.01% 767
2017
Q2
$596K Buy
+11,455
New +$590K ﹤0.01% 1061

Other funds holding LDL

Marshall Wace North America's LDL Position: Q4 2017 in Review

Marshall Wace North America sold out of Lydall, Inc. (LDL) in Q4 2017, closing a stake of 39,918 shares — an estimated $2.27M sold.

Marshall Wace North America first reported a position in LDL in Q2 2017 and held it in 2 quarters. The position peaked at $2.27M in Q3 2017. 161 funds tracked by Wall St. Rank hold LDL as of Q4 2017.

  • Marshall Wace North America reported no remaining Lydall, Inc. position as of Q4 2017 after selling out during the quarter.
  • Marshall Wace North America sold 39,918 Lydall, Inc. shares in Q4 2017, an estimated $2.27M.
  • Marshall Wace North America first reported a position in Lydall, Inc. in Q2 2017 and held it in 2 quarters.
  • Marshall Wace North America's Lydall, Inc. position peaked at $2.27M in Q3 2017.
  • 161 funds tracked by Wall St. Rank held Lydall, Inc. as of Q4 2017.

Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.